Trials / Sponsors / Abcuro, Inc.
Abcuro, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis Inclusion Body Myositis (IBM) | Phase 2 / Phase 3 | 2024-10-21 |
| Completed | A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis Inclusion Body Myositis | Phase 2 / Phase 3 | 2023-02-28 |
| Active Not Recruiting | ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL) T-cell Large Granular Lymphocytic Leukemia | Phase 1 / Phase 2 | 2022-09-28 |
| Completed | A Phase 1 Study of ABC008 in Ascending (Single Ascending Dose/Multiple Ascending Dose) Study in Patients With Inclusion Body Myositis | Phase 1 | 2021-05-25 |